Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 3

Abstract

Introduction: There is scarcity of data in literature regarding the treatment response with Sofosbuvir (SOF) based therapy in Indian patients with chronic Hepatitis-C Virus (HCV) infection. Aim: This study was designed to observe initial treatment response to SOF based therapy in a “real-life” cohort of Indian patients with HCV infection. Materials and Methods: This is a prospective, observational and single center study. A total of 107 patients who were diagnosed with chronic HCV infection and received SOF based treatment between March 2015 and December 2015 were included. The patients were treated with either triple drug regimen [SOF, Ribavirin (RBV) and Pegylated Interferon-α (Peg IFN-α)] or dual drug regimen (SOF and RBV) for either 12 or 24 weeks. The virological responses were obtained at baseline and thereafter weekly (up to four weeks) till viral load became undetected during treatment. Results: A total of 107 patients who received SOF based therapy for chronic HCV infection were included in the study. Mean age of the patients was 48.7±10.7 years. Among included patients, 24 (22.4%) patients were treatment-experienced. Majority of the patients (n=69; 64.5%) were infected with HCV genotype-3. Except one patient, all the included patients achieved virological response up to week-4 of the treatment. There was statistically insignificant association between virological response (up to four week of the treatment) and severity of the disease (cirrhosis and non-cirrhosis) or treatment status (treatment-naïve and treatment-experienced), or HCV genotype (genotype-1 and 3). Conclusion: The results of this observational study demonstrated rapid initial virological response of SOF based therapy in “real-life” cohort of Indian patients with chronic HCV infection. However, long-term follow-up data are needed to ensure the sustained antiviral efficacy of SOF based therapy.

Authors and Affiliations

Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandania

Keywords

Related Articles

Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study

Introduction: Oral cancer is a major global threat to public health. It is one of the most common causes of mortality and morbidity in the modern era. Oral Squamous Cell Carcinoma (OSCC) accounts for over 90% of the mali...

Accuracy and Usability Evaluation of Six Commercially Available Blood Glucose Monitoring Systems

ABSTRACT Introduction: Self-Monitoring of Blood Glucose (SMBG) is essential for achieving glycaemic control in individuals with diabetes mellitus. Aim: The aim of the study was to evaluate the accuracy and the usability...

Clinico-Aetiological Study of Severe and Very Severe Pneumonia in Two Months to Five Years Children in a Tertiary Health Care Centre in Odisha, India

Introduction: Pneumonia is a major cause of mortality under fiveyear-old children. In spite of recent advances in management, there is paucity of data on clinical, aetiological profile of severe and very severe pneumonia...

Screening for Postpartum Depression in a Neonatal Intensive Care Unit and Postnatal Ward with Its Impact on Newborn Care Practices: A Hospital Based Survey

ABSTRACT Introduction: Depression is the fourth leading cause of disability and is estimated to rise to second place by the year 2020. Women of child bearing age are at an increased risk of depression, with an even highe...

Comparison of Retinal Nerve Fiber Layer Thickness in Pregnancy and Postpartum Period

ABSTRACT Introduction: The physiologic retention of water during pregnancy causes oedema in many organs. Optical review of Retinal Nerve Fiber Layer (RNFL), located in the undersurface of the retina, and is clinically us...

Download PDF file
  • EP ID EP334376
  • DOI 10.7860/JCDR/2017/23184.9335
  • Views 117
  • Downloads 0

How To Cite

Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandania (2017). Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection. Journal of Clinical and Diagnostic Research, 11(3), 5-8. https://europub.co.uk/articles/-A-334376